Hyundai Bioscience

048410.KQ

14.28 USD

-0.06

-0.42%

Overview

Last close

14.28 usd

Market cap

568.57M usd

52 week high

30.24 usd

52 week low

12.16 usd

Target price

N/A usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

82.9589

Price/Book Value

15.2294

Enterprise Value

571.36M usd

EV/Revenue

82.8469

EV/EBITDA

-64.6317

Key financials

Revenue TTM

6.90M usd

Gross Profit TTM

2.53M usd

EBITDA TTM

-5.44M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

105.70B usd

Net debt

N/A usd

About

Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.